Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prestige Consumer Healthcare (PBH) Invested Capital (2016 - 2025)

Historic Invested Capital for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $2.9 billion.

  • Prestige Consumer Healthcare's Invested Capital rose 297.06% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year increase of 297.06%. This contributed to the annual value of $2.8 billion for FY2025, which is 166.73% up from last year.
  • Latest data reveals that Prestige Consumer Healthcare reported Invested Capital of $2.9 billion as of Q4 2025, which was up 297.06% from $2.8 billion recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Invested Capital registered a high of $3.1 billion during Q4 2022, and its lowest value of $2.8 billion during Q2 2024.
  • For the 5-year period, Prestige Consumer Healthcare's Invested Capital averaged around $2.9 billion, with its median value being $2.8 billion (2021).
  • Its Invested Capital has fluctuated over the past 5 years, first soared by 807.8% in 2021, then tumbled by 999.82% in 2023.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Invested Capital stood at $3.0 billion in 2021, then increased by 2.04% to $3.1 billion in 2022, then dropped by 10.0% to $2.8 billion in 2023, then dropped by 0.7% to $2.8 billion in 2024, then increased by 2.97% to $2.9 billion in 2025.
  • Its last three reported values are $2.9 billion in Q4 2025, $2.8 billion for Q3 2025, and $2.8 billion during Q2 2025.